Biotech ETF Overview

With 16 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $13.29B. The average expense ratio is 0.76%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $6.72B in assets. In the last trailing year, the best performing Biotech ETF was the CHNA at 13.62%. The most-recent ETF launched in the Biotech space was the Global X Genomics & Biotechnology ETF GNOM in 04/05/19.

Top ETF Performers

LABD Direxion Daily S&P Biotech Bear 3X Shares 13.44%
ZBIO ProShares UltraPro Short Nasdaq Biotechnology 3.79%
BIS ProShares UltraShort Nasdaq Biotechnology 3.48%
CHNA Loncar China BioPharma ETF 1.81%
BBH VanEck Vectors Biotech ETF -1.60%

Bottom ETF Performers

LABU Direxion Daily S&P Biotech Bull 3X Shares -15.14%
BBC Virtus LifeSci Biotech Clinical Trials ETF -7.71%
UBIO ProShares UltraPro Nasdaq Biotechnology -7.36%
GNOM Global X Genomics & Biotechnology ETF -7.01%
CNCR Loncar Cancer Immunotherapy ETF -6.41%

Top Creations

IBB iShares NASDAQ Biotechnology ETF 56.85
LABU Direxion Daily S&P Biotech Bull 3X Shares 37.28
GNOM Global X Genomics & Biotechnology ETF 0.68
CNCR Loncar Cancer Immunotherapy ETF 0
ZBIO ProShares UltraPro Short Nasdaq Biotechnology 0

Top Redemptions

FBT First Trust NYSE Arca Biotechnology Index Fund -894.78
XBI SPDR S&P Biotech ETF -53.51
LABD Direxion Daily S&P Biotech Bear 3X Shares -13.17
BBH VanEck Vectors Biotech ETF -11.98
BIB ProShares Ultra NASDAQ Biotechnology -4.84

AUM Winners

ZBIO ProShares UltraPro Short Nasdaq Biotechnology 6.81%
CHNA Loncar China BioPharma ETF 1.02%
BIS ProShares UltraShort Nasdaq Biotechnology 0.20%
UBIO ProShares UltraPro Nasdaq Biotechnology -0.33%
GNOM Global X Genomics & Biotechnology ETF -2.92%

AUM Losers

LABD Direxion Daily S&P Biotech Bear 3X Shares -29.95%
FBT First Trust NYSE Arca Biotechnology Index Fund -15.47%
CNCR Loncar Cancer Immunotherapy ETF -11.24%
BBC Virtus LifeSci Biotech Clinical Trials ETF -10.05%
XBI SPDR S&P Biotech ETF -9.45%

ETF Report

Sectors In Review: September 2019

Sector ETFs recorded largely positive performance during July.

ETF Report

Sectors In Review: June 2019

Health care and real estate struggled during the month.

Features and News

How To Know What’s In Your ETF

Our free tools and resources can help with your due diligence efforts.

ETF Report

Smart Beta: Beyond The Hype

Despite all the buzz, advisors have reasons to be wary of such strategies.

Features and News

Politics Weigh On Health Care ETFs

Fears of Medicare-for-all are weighing on health care ETFs. Is this an opportunity?

Daily ETF Watch

ETF Week: Zero-Fee Funds Debut

Plus, the first space ETF rolls out.

Features and News

Worst Performing ETFs Of Q1 2019

These ETFs stand out for their poor performance in a strong year for financial markets.

ETF Report

Sectors In Review: April 2019

Sector ETFs had a mostly positive February.

ETF Report

2018 ETF.com Annual Awards

From the ETF of the Year to the People’s Choice ETF, we review the winners of each award, what drove their success and the finalists they competed against.